Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Nature Genetics2006Vol. 39(2), pp. 232–236
Citations Over TimeTop 1% of 2006 papers
Yeshayahu Schlesinger, Ravid Straussman, Ilana Keshet, S. Farkash, Merav Hecht, Joseph Zimmerman, Eran Eden, Zohar Yakhini, Etti Ben-Shushan, Benjamin Reubinoff, Yehudit Bergman, Itamar Simon, Howard Cedar
Related Papers
- → The noncanonical role of EZH2 in cancer(2021)92 cited
- → Targeting EZH2 as cancer therapy(2021)54 cited
- → Targeting EZH2 for Cancer Therapy: Progress and Perspective(2015)64 cited
- → Enhancer of zeste homolog 2: A potential target for tumor therapy(2011)39 cited
- → Abstract 5436: HH2853 is a selective small molecular dual inhibitor of EZH1/2 with potent anti-tumor activities(2022)8 cited